FDA-Drug2026-01-21Class IIMISBRANDING
Alvogen Thyro-Tabs levothyroxine 150mcg recalled for wrong strength tablets in bottle
What this means
One bottle of Alvogen Thyro-Tabs 150mcg levothyroxine tablets (Lot MHA21825) was found to contain 88mcg tablets instead of the labeled 150mcg strength. This mix-up affects only a single bottle distributed nationwide. No injuries have been reported.
- Check if you have Lot MHA21825 (expires December 31, 2027) of Alvogen Thyro-Tabs 150mcg
- Contact your pharmacy or doctor if you have this lot—do not stop taking your medication without guidance
- Your pharmacist can verify the tablet strength and provide correct medication if needed
The agency's original wording
Hazard
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide.
Manufactured in
44 Whippany Rd Ste 300, Morristown, NJ, United States
Products
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0259-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.